We are live on ! Find out more
DMC

Drexel Morgan & Co Portfolio holdings

AUM $682M
1-Year Est. Return 21.01%
This Fund
S&P 500
This Quarter Est. Return
+7.89%
1 Year Est. Return
+21.01%
3 Year Est. Return
+41.96%
5 Year Est. Return
+58.5%
10 Year Est. Return
+182.61%
AUM
$476M
AUM Growth
-$8.28M
Cap. Flow
-$38.9M
Cap. Flow %
-8.17%
Top 10 Hldgs %
74.6%
Holding
56
New
1
Increased
4
Reduced
2
Closed
2

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$26.9M
2
T icon
AT&T
T
+$25.1M
3
NVDA icon
NVIDIA
NVDA
+$242K
4
DIS icon
Walt Disney
DIS
+$97K

Sector Composition

Rank Sector Weight
1 Communication Services 24.87%
2 Industrials 12.68%
3 Technology 11.82%
4 Healthcare 10.17%
5 Financials 9.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GOOGL icon
51
Alphabet (Google) Class A
GOOGL
$4.12T
$235K 0.05%
1,520
AMGN icon
52
Amgen
AMGN
$209B
$234K 0.05%
+750
New +$221K
CSCO icon
53
Cisco
CSCO
$443B
$225K 0.05%
3,650
ADP icon
54
Automatic Data Processing
ADP
$109B
$214K 0.04%
700
CVS icon
55
CVS Health
CVS
$135B
-600,165
Closed -$26.9M
NVDA icon
56
NVIDIA
NVDA
$4.6T
-1,800
Closed -$242K

Similar funds

Drexel Morgan & Co's Q1 2025 Portfolio in Review

As of Q1 2025, Drexel Morgan & Co held 56 positions worth $476M, down 1.7% from $485M the previous quarter. Its ten largest holdings account for 75% of the portfolio.

Drexel Morgan & Co withdrew a net $38.9M in Q1 2025, closing 2 positions and reducing 2 holdings. Its most notable exit was CVS Health, an estimated $26.9M position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 25% of assets, up from 25% a quarter earlier, followed by Industrials and Technology.

Against the trend, Drexel Morgan & Co opened a new position in Amgen worth $234K.

  • Drexel Morgan & Co's largest Q1 2025 buy was Amgen: 750 shares worth $234K.
  • Drexel Morgan & Co added most to United Parcel Service in Q1 2025, an estimated $12M increase.
  • Drexel Morgan & Co's biggest Q1 2025 reduction was AT&T, cutting an estimated $25.1M.
  • Drexel Morgan & Co fully exited CVS Health in Q1 2025, selling an estimated $26.9M.
  • Drexel Morgan & Co's ten largest holdings make up 75% of its $476M portfolio in Q1 2025.
  • Drexel Morgan & Co opened 1 new position and closed 2 in Q1 2025.
  • Drexel Morgan & Co's portfolio value fell 1.7% quarter-over-quarter to $476M.

Based on Drexel Morgan & Co's 13F filing for Q1 2025, filed 8 May 2025.